A new analysis looked at whether genes change how vitamin D affects the chance of moving from prediabetes to type 2 diabetes. The study re-examined a large US clinical trial that gave a high daily vitamin D dose or a placebo to more than two thousand adults with prediabetes.
Researchers used DNA from about 2,100 participants to compare genetic subgroups. They found that some genetic types had a lower risk of developing diabetes when taking the high dose, while other types did not respond. Authors say people should not start high-dose vitamin D without medical advice, and more research is needed to know who may benefit.
Difficult words
- gene — part of a cell that carries biological informationgenes
- prediabetes — a condition with higher blood sugar before diabetes
- clinical trial — a controlled medical study with people
- placebo — a fake treatment with no active medicine
- dose — an amount of medicine or supplement
- genetic — relating to genes and inherited traits
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Would you ask a doctor before taking a high dose of vitamin D? Why or why not?
- Do you think genetic differences can change how a treatment works? Give one reason.
- If you or a family member had prediabetes, would you want more research or tests to know who benefits? Why?
Related articles
Few new antibiotics for children amid rising resistance
Global experts warn that few child-friendly antibiotics are being developed while antimicrobial resistance already causes millions of deaths. A 2026 Benchmark finds fewer drugs in company pipelines and a shortage of medicines for under-five children.
Teen drug use in the US stays near pandemic low
For the fifth year in a row, use of most substances among US teenagers remains close to the low point reached in 2021, according to the University of Michigan's Monitoring the Future survey. Some drugs rose slightly, and researchers say monitoring must continue.